Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Healthcare Services (HCSG) over the last 17 years, with Q4 2025 value amounting to $16.0 million.

  • Healthcare Services' Free Cash Flow fell 5397.25% to $16.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $139.2 million, marking a year-over-year increase of 46874.85%. This contributed to the annual value of $139.2 million for FY2025, which is 46874.85% up from last year.
  • According to the latest figures from Q4 2025, Healthcare Services' Free Cash Flow is $16.0 million, which was down 5397.25% from $70.0 million recorded in Q3 2025.
  • In the past 5 years, Healthcare Services' Free Cash Flow registered a high of $70.0 million during Q3 2025, and its lowest value of -$31.6 million during Q1 2022.
  • In the last 5 years, Healthcare Services' Free Cash Flow had a median value of $11.4 million in 2022 and averaged $11.0 million.
  • As far as peak fluctuations go, Healthcare Services' Free Cash Flow plummeted by 129113.88% in 2022, and later skyrocketed by 230154.48% in 2025.
  • Healthcare Services' Free Cash Flow (Quarter) stood at $29.9 million in 2021, then fell by 26.99% to $21.8 million in 2022, then surged by 119.99% to $48.0 million in 2023, then decreased by 27.57% to $34.8 million in 2024, then tumbled by 53.97% to $16.0 million in 2025.
  • Its Free Cash Flow stands at $16.0 million for Q4 2025, versus $70.0 million for Q3 2025 and $27.4 million for Q2 2025.